Yabing Zheng

602 total citations
20 papers, 477 citations indexed

About

Yabing Zheng is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yabing Zheng has authored 20 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yabing Zheng's work include Peptidase Inhibition and Analysis (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cell Adhesion Molecules Research (4 papers). Yabing Zheng is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cell Adhesion Molecules Research (4 papers). Yabing Zheng collaborates with scholars based in China. Yabing Zheng's co-authors include Xiaotian Chang, Lin Wang, Bing Xu, Jihong Pan, Xinfeng Yan, Guanhua Song, Xia Li, Xinfeng Yan, Huilin Li and Yan Zhao and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Oncotarget.

In The Last Decade

Yabing Zheng

20 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yabing Zheng China 14 278 124 105 97 50 20 477
Gareth W. Fearnley United Kingdom 12 257 0.9× 69 0.6× 108 1.0× 78 0.8× 17 0.3× 19 414
M. Anthony Leesnitzer United States 10 288 1.0× 122 1.0× 33 0.3× 179 1.8× 65 1.3× 11 536
Matthew Adlam United States 10 509 1.8× 96 0.8× 218 2.1× 129 1.3× 38 0.8× 11 738
Adam J. Cotterell Australia 9 190 0.7× 79 0.6× 80 0.8× 27 0.3× 13 0.3× 10 506
Jacqueline Sayyah United States 9 368 1.3× 78 0.6× 43 0.4× 178 1.8× 16 0.3× 11 534
Parag P. Patwardhan United States 8 349 1.3× 62 0.5× 98 0.9× 134 1.4× 21 0.4× 16 593
Smita Kale India 5 209 0.8× 127 1.0× 76 0.7× 119 1.2× 136 2.7× 6 501
Yi Fu China 11 374 1.3× 163 1.3× 100 1.0× 63 0.6× 13 0.3× 20 600
Ada Pesapane Italy 12 208 0.7× 101 0.8× 51 0.5× 81 0.8× 9 0.2× 16 384

Countries citing papers authored by Yabing Zheng

Since Specialization
Citations

This map shows the geographic impact of Yabing Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Zheng more than expected).

Fields of papers citing papers by Yabing Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yabing Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Zheng. The network helps show where Yabing Zheng may publish in the future.

Co-authorship network of co-authors of Yabing Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yabing Zheng. A scholar is included among the top collaborators of Yabing Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yabing Zheng. Yabing Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Beibei, et al.. (2024). The prognostic value and its relationship with immune infiltration of ACLY in clear cell renal cell carcinoma. Translational Oncology. 47. 102056–102056. 5 indexed citations
2.
Chang, Xiaotian, Hui Wu, Huilin Li, Honglei Li, & Yabing Zheng. (2022). PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8. BMC Gastroenterology. 22(1). 25–25. 17 indexed citations
3.
Xu, Jingwen, Yabing Zheng, Yaqing Zhao, et al.. (2022). Succinate/IL-1β Signaling Axis Promotes the Inflammatory Progression of Endothelial and Exacerbates Atherosclerosis. Frontiers in Immunology. 13. 817572–817572. 34 indexed citations
4.
Huang, Ping, Yabing Zheng, Wenming Cao, et al.. (2022). Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy. Frontiers in Pharmacology. 13. 883600–883600. 3 indexed citations
5.
Lei, Lei, Linfeng Zheng, Ping Huang, et al.. (2019). <p>A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation</p>. OncoTargets and Therapy. Volume 12. 2931–2936. 3 indexed citations
6.
Wang, Li, Yabing Zheng, Na Liang, et al.. (2019). PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer. Cancer Cell International. 19(1). 277–277. 11 indexed citations
7.
Chang, Xiaotian, et al.. (2019). PADI3 induces cell cycle arrest via the Sirt2/AKT/p21 pathway and acts as a tumor suppressor gene in colon cancer. Cancer Biology and Medicine. 16(4). 729–742. 17 indexed citations
8.
Liu, Yudong, Peng Zhang, Yabing Zheng, et al.. (2018). Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to Aβ1−42 Oligomers Induced Neurotoxicity. Neurochemical Research. 43(10). 2008–2015. 7 indexed citations
9.
Song, Yan, Guangping Wu, Qianqian Kong, et al.. (2017). N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3. Oncology Letters. 13(5). 3599–3607. 5 indexed citations
10.
Guo, Wei, Yabing Zheng, Bing Xu, et al.. (2017). Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors. OncoTargets and Therapy. Volume 10. 1475–1485. 38 indexed citations
11.
Wang, Huifeng, Bing Xu, Xiaoqian Zhang, et al.. (2016). PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling. Cancer Cell International. 16(1). 61–61. 34 indexed citations
12.
Zheng, Yabing, Gang Zhao, Bing Xu, et al.. (2016). PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels. Oncotarget. 7(38). 62159–62176. 28 indexed citations
13.
Zhao, Yan, Xinfeng Yan, Xia Li, et al.. (2016). PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis. Inflammation Research. 65(10). 815–825. 40 indexed citations
14.
Zheng, Yabing, Bing Xu, Yan Zhao, et al.. (2015). CA1 contributes to microcalcification and tumourigenesis in breast cancer. BMC Cancer. 15(1). 679–679. 28 indexed citations
15.
Wang, Lin, Guanhua Song, Yabing Zheng, et al.. (2015). Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 227–227. 45 indexed citations
16.
Wang, Lin, Guanhua Song, Yabing Zheng, et al.. (2015). miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis. Cellular and Molecular Immunology. 13(6). 839–849. 35 indexed citations
17.
Cui, Yingying, Li Yan, Jing Zhou, et al.. (2015). The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion. Tumor Biology. 37(4). 5375–5383. 24 indexed citations
18.
Wang, Lin, et al.. (2013). Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis. PLoS ONE. 8(1). e53301–e53301. 33 indexed citations
19.
Zheng, Yabing, et al.. (2012). Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction. BMC Musculoskeletal Disorders. 13(1). 256–256. 31 indexed citations
20.
Chang, Xiaotian, et al.. (2012). Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis. Arthritis Research & Therapy. 14(4). R176–R176. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gareth W. Fearnley Breakdown of academic impact, for papers by M. Anthony Leesnitzer Breakdown of academic impact, for papers by Matthew Adlam Breakdown of academic impact, for papers by Adam J. Cotterell Breakdown of academic impact, for papers by Jacqueline Sayyah Breakdown of academic impact, for papers by Parag P. Patwardhan Breakdown of academic impact, for papers by Smita Kale Breakdown of academic impact, for papers by Yi Fu Breakdown of academic impact, for papers by Ada Pesapane
Rankless by CCL
2026